These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35091890)

  • 1. Antibody glycosylation in COVID-19.
    Pongracz T; Vidarsson G; Wuhrer M
    Glycoconj J; 2022 Jun; 39(3):335-344. PubMed ID: 35091890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy.
    Adhikari EH; Lu P; Kang YJ; McDonald AR; Pruszynski JE; Bates TA; McBride SK; Trank-Greene M; Tafesse FG; Lu LL
    J Infect Dis; 2024 Feb; 229(2):462-472. PubMed ID: 37815524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.
    Pongracz T; Nouta J; Wang W; van Meijgaarden KE; Linty F; Vidarsson G; Joosten SA; Ottenhoff THM; Hokke CH; de Vries JJC; Arbous SM; Roukens AHE; Wuhrer M; ;
    EBioMedicine; 2022 Apr; 78():103957. PubMed ID: 35334306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity.
    Siekman SL; Pongracz T; Wang W; Nouta J; Kremsner PG; da Silva-Neto PV; Esen M; Kreidenweiss A; Held J; Trapé ÁA; Fendel R; de Miranda Santos IKF; Wuhrer M;
    Front Immunol; 2022; 13():993354. PubMed ID: 36389824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
    Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
    Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients.
    Plūme J; Galvanovskis A; Šmite S; Romanchikova N; Zayakin P; Linē A
    J Transl Med; 2022 Apr; 20(1):176. PubMed ID: 35428263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection.
    Okuya K; Hattori T; Saito T; Takadate Y; Sasaki M; Furuyama W; Marzi A; Ohiro Y; Konno S; Hattori T; Takada A
    Microbiol Spectr; 2022 Apr; 10(2):e0155321. PubMed ID: 35319248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Puenpa J; Wanlapakorn N; Chirathaworn C; Sudhinaraset N; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Ayuthaya TPN; Brukesawan C; Intharasongkroh D; Chaiwanichsiri D; Issarasongkhram M; Kitphati R; Mungaomklang A; Thitithanyanont A; Nagavajara P; Poovorawan Y
    PLoS One; 2022; 17(4):e0267102. PubMed ID: 35446889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of Glycosylation in COVID-19 Infection.
    Petrović T; Lauc G; Trbojević-Akmačić I
    Adv Exp Med Biol; 2021; 1325():239-264. PubMed ID: 34495539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
    Anderson EM; Diorio C; Goodwin EC; McNerney KO; Weirick ME; Gouma S; Bolton MJ; Arevalo CP; Chase J; Hicks P; Manzoni TB; Baxter AE; Andrea KP; Burudpakdee C; Lee JH; Vella LA; Henrickson SE; Harris RM; Wherry EJ; Bates P; Bassiri H; Behrens EM; Teachey DT; Hensley SE
    J Pediatric Infect Dis Soc; 2021 May; 10(5):669-673. PubMed ID: 33263756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.